Filter
426
Text search:
drug
import
Featured
Recommendations
27
New Publications
123
Language
Document type
No document type
232
Studies & Reports
81
Guidelines
68
Manuals
17
Strategic & Response Plan
16
Training Material
4
Situation Updates
3
Fact sheets
3
Resource Platforms
2
Countries / Regions
India
24
Global
15
South Africa
14
Uganda
12
Nepal
12
Western and Central Europe
12
Sierra Leone
11
Kenya
11
Liberia
10
Nigeria
10
Tanzania
9
Ghana
8
Zimbabwe
8
South–East Asia Region
8
Ethiopia
7
Zambia
7
Rwanda
7
Bangladesh
7
Malawi
6
Ukraine
5
Myanmar / Burma
5
Venezuela
5
Burkina Faso
4
Senegal
4
Syria
4
Indonesia
4
Namibia
4
Eswatini/ Swaziland
4
Mozambique
3
Lesotho
3
Latin America and the Carribbean
3
Africa
3
Eastern Europe
3
Congo, Democratic Republic of
2
Haiti
2
Iraq
2
Germany
2
Lebanon
2
Cambodia
2
China
2
Benin
2
Botswana
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Laos
2
Jamaica
2
Guinea
1
USA
1
Cameroon
1
Philippines
1
Pakistan
1
South Sudan
1
Jordan
1
Afghanistan
1
Thailand
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Serbia
1
Colombia
1
Bolivia
1
Sri Lanka
1
Chile
1
Yemen
1
East and Southern Africa
1
Asia
1
Bhutan
1
Poland
1
North Korea
1
Albania
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
207
Clinical Guidelines
35
Public Health
24
Key Resources
11
Pharmacy & Technologies
11
Women & Child Health
5
Toolboxes
AMR
58
HIV
32
Mental Health
30
Pharmacy
26
TB
23
COVID-19
19
Rapid Response
11
Ebola
7
Conflict
7
NCDs
7
Caregiver
5
Global Health Education
3
Planetary Health
3
NTDs
3
Natural Hazards
2
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Cholera
1
Zika
1
Social Ethics
1
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
2nd edition
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of
...
HIV drug resistance , Users Manual
December 2017
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and a
...
A summary of the national drug situation
EMCDDA Insights - 11
Accessed: 14.03.2019
Accessed: 28.03.2019
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a
...
